Related Experiment Video
Updated: May 12, 2025

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Possible Capecitabine-Induced Coronary Vasospasm and Myocardial Infarction.
Deepa Soodi1, Vinod Kumar Reddy Cirra2, Guruprasad D Naik3,1
1Cardiology, Marshfield Clinic Health System, Marshfield, USA.
Capecitabine, a cancer drug, can cause coronary vasospasm, leading to heart attacks. Promptly recognizing and stopping this cardiotoxicity is crucial for patient safety.
Area of Science:
- Oncology
- Cardiology
- Pharmacology
Background:
- Capecitabine is a widely used oral chemotherapy agent, serving as a precursor to 5-fluorouracil.
- It is approved for the treatment of various cancers, including breast and colorectal cancer.
- While effective, understanding its potential adverse effects is critical for patient management.
Related Concept Videos
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Vascular Spasm
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

